Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
about
Temperament type specific metabolite profiles of the prefrontal cortex and serum in cattleCysteine and hydrogen sulphide in the regulation of metabolism: insights from genetics and pharmacologyThe Role of the Ubiquitously Expressed Transcription Factor Sp1 in Tissue-specific Transcriptional Regulation and in DiseaseNo quiet surrender: molecular guardians in multiple sclerosis brainModes of physiologic H2S signaling in the brain and peripheral tissuesN-Acetylcysteine improves mitochondrial function and ameliorates behavioral deficits in the R6/1 mouse model of Huntington's diseaseSulfheme formation during homocysteine S-oxygenation by catalase in cancers and neurodegenerative diseasesNew method for quantification of gasotransmitter hydrogen sulfide in biological matrices by LC-MS/MS.Photoacoustic probes for real-time tracking of endogenous H2S in living mice.Hydrogen sulfide ameliorates chronic renal failure in rats by inhibiting apoptosis and inflammation through ROS/MAPK and NF-κB signaling pathways.The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson's diseaseH2S production by reactive oxygen species in the carotid body triggers hypertension in a rodent model of sleep apnea.Hydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathwaysLoss of cysteinyl-tRNA synthetase (CARS) induces the transsulfuration pathway and inhibits ferroptosis induced by cystine deprivationProtein kinase G-regulated production of H2S governs oxygen sensing.Chemical probes for molecular imaging and detection of hydrogen sulfide and reactive sulfur species in biological systems.Cystathionine Levels in Patients With Huntington DiseaseHuntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase.Hydrogen sulfide and polysulfides as signaling molecules.Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington's disease in ratsHypothalamic-Pituitary Axis Regulates Hydrogen Sulfide Production.CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.Transcriptional control of amino acid homeostasis is disrupted in Huntington's diseaseMutations in mitochondrial enzyme GPT2 cause metabolic dysfunction and neurological disease with developmental and progressive featuresOxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.Animal models of Huntington's disease for translation to the clinic: best practices.Calorie restriction and methionine restriction in control of endogenous hydrogen sulfide production by the transsulfuration pathway.Overexpression of cystathionine γ-lyase suppresses detrimental effects of spinocerebellar ataxia type 3.Chemiluminescent Probes for Imaging H2S in Living AnimalsL-Cysteine metabolism and its nutritional implications.Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.H2S: A Novel Gasotransmitter that Signals by Sulfhydration.Huntington's Disease: Pathogenic Mechanisms and Therapeutic Targets.Dual-Emission Channels for Simultaneous Sensing of Cysteine and Homocysteine in Living Cells.The in vivo evidence for regulated necrosis.Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington's disease.Huntington's Disease: Mechanisms of Pathogenesis and Therapeutic Strategies.A New Hope for a Devastating Disease: Hydrogen Sulfide in Parkinson's Disease.Identification of Proteins Interacting with Cytoplasmic High-Mobility Group Box 1 during the Hepatocellular Response to Ischemia Reperfusion Injury.Role of hydrogen sulfide within the dorsal motor nucleus of the vagus in the control of gastric function in rats.
P2860
Q21090552-8C450E15-529B-4AA5-AFC7-70174C687220Q26782965-18DF7E5E-2ABB-4429-9141-60D4FBC464F2Q28076855-8D2A2450-51F1-45CB-BE0F-420B320D5E15Q28084633-4757A2F4-88F8-41FA-8C4F-1D15ACE1D1A3Q28386668-CA32AA66-6B80-4873-8E11-71471E84A8D8Q28387085-4E419291-BA66-4274-9853-186C4CD700B2Q28821025-18320A63-A5EF-40F7-8360-90A2BF1329B6Q33559882-8F633FD0-C8EB-4D6F-B11B-C7284F3F99EFQ33609652-352A125D-9529-437C-8F7A-CB7349F5F9A1Q33673500-3FC0B795-986B-4FFC-A151-BE9C4D49D31DQ33850971-305E54A4-2B19-4C24-BBA9-9A8735B75973Q33893748-AA7519C0-17FB-4657-8353-96ACAB5FDC81Q33895006-9F4C55CE-B197-4A08-80D9-2EBF899841FFQ34044497-99D46956-DF38-42EB-A025-CC9102DD91DDQ35565640-53928803-32ED-4AD6-9602-F909350E2F8DQ35685352-1415AF52-3924-462B-9D9D-8896A7CEDF28Q35798834-3B5CB4A3-977C-4682-92FA-6EA6C15E5DC8Q35946323-8EFA4B5B-9CFF-4DBD-82E9-541D722B24BCQ36055721-3329AF8E-702A-4F7C-8F8B-72B6C6477C7CQ36078124-F2727619-6818-44C2-8723-63E45069BAB8Q36395221-6C95F815-371C-4262-9C27-C3EC405B3DE2Q36615488-78C73B1F-30AF-4C9D-ADCE-510F87C82C47Q37161760-0252E7BC-A759-427F-B6CF-CB773AAA226EQ37281503-A7AD93B5-6AAC-4E66-8451-69E22A09D6B4Q37643688-E7358C4D-F145-4FBA-AC4B-2EEB1CD8D4C9Q38248687-1584D797-8591-4B8E-925E-E29C43EE4833Q38293712-08651D65-974E-471D-AD37-4F32479ED822Q38357564-805EE2EE-C293-42EE-904B-794D79D01CE8Q38428354-F9F5FAC9-53AD-4363-9679-6E813BE817CCQ38451870-FB0E177B-4CC8-4E5F-B153-477FC35F714FQ38580123-FB3D605B-6FE3-41BC-B212-091DDE2E0E2FQ38600019-2C1D47EF-5BB0-4CA6-9BB8-653366FD323BQ38663090-F04A0540-8D59-4C84-A1AA-AB105D36CF24Q38677428-34CE83CF-CDCB-4582-9713-D6F639899327Q38809791-503E8BF7-F480-4B8F-BE4F-AB7F77F34FECQ38925490-2DC4A2BC-ED90-4955-8A75-2508780E97CEQ39035495-0AB16A5C-3AA0-4032-A42D-4AD75B653B94Q39325806-C6CC7286-55F2-4B59-B8B8-A0C44AE14DE2Q40302106-BA9015C0-D069-4EDF-A194-5298A6AFF571Q41217057-1BDC599A-6A45-4BE3-81C4-EBD299EB26B5
P2860
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@ast
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@en
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@nl
type
label
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@ast
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@en
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@nl
prefLabel
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@ast
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@en
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@nl
P2093
P2860
P356
P1433
P1476
Cystathionine γ-lyase deficiency mediates neurodegeneration in Huntington's disease
@en
P2093
Adele M Snowman
Bindu D Paul
Jiyoung Y Cha
Juan I Sbodio
M Scott Vandiver
Risheng Xu
P2860
P2888
P304
P356
10.1038/NATURE13136
P407
P577
2014-03-26T00:00:00Z
P6179
1037896503